Duncker Streett & Co’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.76K Hold
437
﹤0.01% 444
2026
Q1
$4.95K Hold
437
﹤0.01% 455
2025
Q4
$3.5K Hold
437
﹤0.01% 469
2025
Q3
$20.9K Hold
437
﹤0.01% 389
2025
Q2
$5.46K Hold
437
﹤0.01% 453
2025
Q1
$7.61K Hold
437
﹤0.01% 432
2024
Q4
$16.6K Hold
437
﹤0.01% 414
2024
Q3
$14.6K Hold
437
﹤0.01% 393
2024
Q2
$14.8K Hold
437
﹤0.01% 395
2024
Q1
$39.3K Hold
437
0.01% 332
2023
Q4
$20.9K Hold
437
﹤0.01% 368
2023
Q3
$8.09K Hold
437
﹤0.01% 417
2023
Q2
$7.56K Hold
437
﹤0.01% 417
2023
Q1
$11K Buy
437
+150
+52% +$17.1K ﹤0.01% 394
2022
Q4
$55.3K Buy
+287
New +$29.5K 0.01% 294
2022
Q3
Sell
-315
Closed -$24K 478
2022
Q2
$24K Hold
315
0.01% 352
2022
Q1
$33K Buy
+315
New +$60.2K 0.01% 341

Other funds holding KRRO

Duncker Streett & Co's KRRO Position: Q2 2026 in Review

Duncker Streett & Co held its Korro Bio (KRRO) position steady in Q2 2026 at 437 shares worth $5.76K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Duncker Streett & Co first reported a position in KRRO in Q1 2022 and has held it in 17 quarters since. The position peaked at $55.3K in Q4 2022. 17 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Duncker Streett & Co held 437 shares of Korro Bio worth $5.76K as of Q2 2026.
  • Duncker Streett & Co left its Korro Bio share count unchanged in Q2 2026.
  • Korro Bio made up ﹤0.01% of Duncker Streett & Co's portfolio in Q2 2026, its #444 holding.
  • Duncker Streett & Co first reported a position in Korro Bio in Q1 2022 and has held it in 17 quarters since.
  • Duncker Streett & Co's Korro Bio position peaked at $55.3K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Duncker Streett & Co's 13F filing for Q2 2026, filed 28 Jul 2026.